Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Diageo cut its guidance for the second time this fiscal year as the British distiller struggles to revive demand in the US and China, in an early challenge for new Chief Executive Officer Dave Lewis.
- Banco Santander vowed to grow net income to more than €20 billion ($23.6 billion) in 2028, ratcheting up its financial goals shortly after announcing the acquisition of US lender Webster Financial Corp.
- Trainline shares fall as much as 8.5%, hitting the lowest level since March 2022, after the online train ticketing platform announced that CEO Jody Ford intends to step down after five years in the role. The change of leadership is “untimely,” according to JPMorgan analysts.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- HSBC reported better-than-estimated earnings for 2025 as Europe’s largest bank closed out a year in which its market value broke through £200 billion ($270 billion) for the first time in its history.
- Aston Martin will cut as much as a fifth of its roughly 3,000 workforce, as the ailing luxury-car maker grapples with an elusive turnaround made harder by US President Donald Trump’s tariffs.
- Diageo cut its guidance for the second time this fiscal year as the British distiller struggles to revive demand in the US and China, in an early challenge for new Chief Executive Officer Dave Lewis.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Cava Group (CAVA) reported fourth-quarter sales growth and gave a rosy outlook for 2026, outperforming its fast-casual rivals and bucking expectations for a slowdown. Sales from established restaurants are seen expanding 3% to 5% this year, with the company citing price increases and customers opting for more expensive options as helping to offset a decline in store visits. Cava shares jumped 9.2% after the close of regular trading in New York, with the stock having advanced nearly 16% so far this year.

- PayPal (PYPL) closed up 6.7% to $47.01 in New York Tuesday, giving it a market value of $43.3 billion after Bloomberg reported that Stripe is considering an acquisition of all or parts of PayPal Holdings Inc., according to people familiar with the matter. The deliberations are early and there's no certainty they'll lead to a transaction, the people said.

- Novo Nordisk (NOV) next-generation weight-loss drug CagriSema had disappointing trial results, sparking calls for a radical shift in the company's strategy. Some investors are urging Novo to diversify away from diabetes and obesity, citing the risk of relying on these two areas, and suggesting fields such as rare diseases, heart disease, or cancer treatment.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Kristine Aquino, Carol Massar and Tim Stenovec

- Advanced Micro Devices (AMD) shares rise after news that Meta Platforms will deploy data center gear based on processors from AMD in a deal worth “double-digit billions” of dollars per gigawatt.

- Texas Instruments (TXN) shares slid nearly 5% after the chipmaker indicated that spending on new plants and equipment will remain higher than some investors had anticipated. During a presentation Tuesday, the company said that the expenditures will be $2 billion to $3 billion this year, reiterating a previous stance. The target for 2027 and beyond “depends on revenue and expected growth,” it said.

- Keysight Technologies (KEYS) shares jump 17% in premarket trading after the measurement instruments company guided for above-20% growth for revenue and earnings in FY26, beating estimates. Booming AI workloads, along with faster growth in other business areas including wireless and defense, are all boosting growth, according to analysts.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Home Depot (HD) shares rise after the company reported a key sales metric that beat expectations in the latest quarter on steady demand, though the retailer cautioned that macroeconomic challenges remain.
-Advanced Micro Devices (AMD) shares gain after news Meta Platforms will deploy data center gear based on processors from AMD in a deal worth “double-digit billions” of dollars per gigawatt.
- Novo Nordisk (NOVOB) next-generation weight-loss drug CagriSema had disappointing trial results, sparking calls for a radical shift in the company's strategy. Some investors are urging Novo to diversify away from diabetes and obesity, citing the risk of relying on these two areas, and suggesting fields such as rare diseases, heart disease, or cancer treatment.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Home Depot (HD) shares rise after the company reported a key sales metric that beat expectations in the latest quarter on steady demand, though the retailer cautioned that macroeconomic challenges remain.

- Advanced Micro Devices (AMD) shares gain after news Meta Platforms will deploy data center gear based on processors from AMD in a deal worth “double-digit billions” of dollars per gigawatt.

- Intuit (INTU) shares rise after news that the company announced a multi-year partnership with Anthropic to bring custom AI agents to mid-market businesses and deliver personalized experiences for consumers and businesses.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Advanced Micro Devices (AMD) shares rise after news that Meta Platforms will deploy data center gear based on processors from AMD in a deal worth “double-digit billions” of dollars per gigawatt.

- Warner Bros. Discovery (WBD) is considering a new takeover proposal from Paramount Skydance Corp., the latest salvo in a months-long battle for control of one of Hollywood’s most famed studios. The parent of HBO and CNN said its board will review the proposal and respond, according to a statement Tuesday

- Eli Lilly (LLY) shares fall after news Novo Nordisk plans to slash the US list prices for its medicines Wegovy and Ozempic next year. The monthly price will be set at $675, a cut of as much as 50%, to make the medicines more competitive in the obesity market.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Keurig Dr Pepper (KDP) offered an upbeat forecast for its full-year sales, saying it expected a boost from its planned purchase of Dutch coffee maker JDE Peet’s NV later in 2026.
The soda and coffee company said it expected net sales between $25.9 billion and $26.4 billion for 2026, topping analysts’ expectations of $18.5 billion.

- Planet Fitness (PLNT) shares are down after the operator of fitness clubs gave an outlook for 2026 adjusted Ebitda growth that implies the profit measure will fall short of Wall Street expectations.

- Hims & Hers Health (HIMS) shares fall on continued uncertainty about whether the telehealth company can keep selling copycat weight-loss drugs that are mired in legal and regulatory risks.

See omnystudio.com/listener for privacy information.